OCUPHIRE PHARMA INC (OCUP)
US67577R1023 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 50.50M | 42.63M | 24.53M | 16.40M | 9.22M | |||
| Marketable Securities | 15.00K | 50.00K | 220.00K | N/A | 3.00M | |||
| Receivables | 2.33M | 4.85M | N/A | N/A | N/A | |||
| Other Current Assets | 1.10M | 1.45M | 1.31M | 1.27M | 450.00K | |||
| Total Current Assets | 53.95M | 48.99M | 26.07M | 17.67M | 12.66M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 10.00K | 10.00K | 10.00K | 280.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 30.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 0.00 | 0.00 | 10.00K | 10.00K | 310.00K | |||
| TOTAL ASSETS | 53.95M | 48.99M | 26.08M | 17.68M | 12.97M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 540.00K | 0.00 | 0.00 | |||
| Accrued Expenses | 1.81M | 1.37M | 1.73M | 1.97M | 920.00K | |||
| Accounts Payable | 2.15M | 1.07M | 1.58M | 1.21M | 490.00K | |||
| Other Current Liabilities | 74.00K | 320.00K | N/A | 0.00 | 1.50M | |||
| Total Current Liabilities | 4.04M | 2.75M | 3.86M | 3.19M | 2.91M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 0.00 | 27.96M | 110.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 27.96M | 100.00K | |||
| TOTAL LIABILITIES | 4.04M | 2.75M | 3.86M | 31.15M | 3.01M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -81.47M | -71.48M | -89.37M | -32.68M | -163.32M | |||
| Additional Paid In Capital | 131.37M | 117.72M | 111.59M | 19.21M | 173.28M | |||
| Common Shares | 2.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Shares Outstanding | 23.98M | 20.86M | 18.85M | 10.88M | 1.00M | |||
| Tangible Book Value per Share | 2.08 | 2.22 | 1.18 | -1.24 | 9.96 | |||
| Total Shareholders' Equity | 49.91M | 46.24M | 22.22M | -13.47M | 9.96M | |||
| TOTAL LIABILITIES AND EQUITY | 53.95M | 48.99M | 26.08M | 17.68M | 12.97M | |||
| Statistics | ||||||||
| Current Ratio | 13.35 | 17.81 | 6.75 | 5.54 | 4.35 | |||
| Return On Assets (ROA) | -18.51% | 36.52% | -217.37% | -139.25% | -66.62% | |||
| Return On Equity (ROE) | -20.01% | 38.69% | -255.13% | N/A | -86.75% | |||
| Return On Invested Capital (ROIC) | N/A | 31.15% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 404.54% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | 404.54% | N/A | N/A | N/A | |||
All data in USD